182 related articles for article (PubMed ID: 24164486)
1. On the characterization of medicated plasters containing NSAIDs according to novel indications of USP and EMA: adhesive property and in vitro skin permeation studies.
Cilurzo F; Gennari CG; Selmin F; Franzé S; Musazzi UM; Minghetti P
Drug Dev Ind Pharm; 2015 Feb; 41(2):183-9. PubMed ID: 24164486
[TBL] [Abstract][Full Text] [Related]
2. Adhesive properties: a critical issue in transdermal patch development.
Cilurzo F; Gennari CG; Minghetti P
Expert Opin Drug Deliv; 2012 Jan; 9(1):33-45. PubMed ID: 22171789
[TBL] [Abstract][Full Text] [Related]
3. Application of methyl methacrylate copolymers to the development of transdermal or loco-regional drug delivery systems.
Cilurzo F; Selmin F; Gennari CG; Montanari L; Minghetti P
Expert Opin Drug Deliv; 2014 Jul; 11(7):1033-45. PubMed ID: 24766369
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch.
Ganti SS; Bhattaccharjee SA; Murnane KS; Blough BE; Banga AK
Int J Pharm; 2018 Oct; 550(1-2):71-78. PubMed ID: 30125654
[TBL] [Abstract][Full Text] [Related]
5. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
Soler LI; Boix A; Lauroba J; Colom H; Domenech J
Drug Dev Ind Pharm; 2012 Oct; 38(10):1171-8. PubMed ID: 22204649
[TBL] [Abstract][Full Text] [Related]
6. Design of in vitro skin permeation studies according to the EMA guideline on quality of transdermal patches.
Cilurzo F; Musazzi UM; Franzé S; Fedele G; Minghetti P
Eur J Pharm Sci; 2018 Dec; 125():86-92. PubMed ID: 30236552
[TBL] [Abstract][Full Text] [Related]
7. Generic patches containing fentanyl: In vitro equivalence and abuse deterrent evaluation according to EMA and FDA guidelines.
Padula C; Pescina S; Nicoli S; Santi P
Int J Pharm; 2018 Feb; 537(1-2):57-63. PubMed ID: 29253583
[TBL] [Abstract][Full Text] [Related]
8. Tuning the rheological properties of an ammonium methacrylate copolymer for the design of adhesives suitable for transdermal patches.
Quaroni GMG; Gennari CGM; Cilurzo F; Ducouret G; Creton C; Minghetti P
Eur J Pharm Sci; 2018 Jan; 111():238-246. PubMed ID: 28987537
[TBL] [Abstract][Full Text] [Related]
9. [Pharmaceutical Properties of Anti-inflammatory Analgesic Patches Using Acrylic Polymer].
Gato K; Shikaku R; Kato S; Yoshimura-Fujii M; Koide T; Fukami T
Yakugaku Zasshi; 2020; 140(9):1175-1183. PubMed ID: 32879249
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of percutaneous permeation of flurbiprofen and ketoprofen after application of transdermal patches using a lateral sectioning approach in hairless rats.
Goi N; Morishita K; Taniguchi A; Ishii T; Saitoh K
Pharm Dev Technol; 2010 Dec; 15(6):658-65. PubMed ID: 20883157
[TBL] [Abstract][Full Text] [Related]
11. Transdermal Adhesive Patches Loaded with Ketoprofen Evaluated by Dynamic Detection of Percutaneous Absorption.
Wang M; Li L; Xie J; Sun Y; Ling G; He Z
AAPS PharmSciTech; 2017 Aug; 18(6):2141-2148. PubMed ID: 28035612
[TBL] [Abstract][Full Text] [Related]
12. A strong, silk protein-inspired tissue adhesive with an enhanced drug release mechanism for transdermal drug delivery.
Song H; Wang L; Wu J; Liu J; Liu C; Guo J; Fang L
Acta Biomater; 2024 Jun; 181():133-145. PubMed ID: 38641185
[TBL] [Abstract][Full Text] [Related]
13. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
[TBL] [Abstract][Full Text] [Related]
14. Formulation and biopharmaceutical evaluation of a transdermal patch containing aceclofenac.
Rhee YS; Nguyen T; Park ES; Chi SC
Arch Pharm Res; 2013 May; 36(5):602-7. PubMed ID: 23475315
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of adhesive properties of transdermal therapeutic systems containing nitroglycerin.
Minghetti P; Casiraghi A; Cilurzo F; Montanari L
Boll Chim Farm; 2001; 140(2):63-7. PubMed ID: 11417388
[TBL] [Abstract][Full Text] [Related]
16. Novel biomaterial for transdermal application: in vitro and in vivo characterization.
Mundada AS; Avari JG
Drug Deliv; 2011 Aug; 18(6):424-31. PubMed ID: 21554152
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Adhesives on the Properties of Adhesion, Drug Release and Skin Permeation of Lidocaine Tapes].
Sugino M; Mikami M; Ishihara T; Hosoya O; Juni K
Yakugaku Zasshi; 2015; 135(8):977-85. PubMed ID: 26234356
[TBL] [Abstract][Full Text] [Related]
18. Enhancing Transdermal Delivery: Investigating the Impact of Permeation Promoters on Ibuprofen Release and Penetration from Medical Patches-In Vitro Research.
Bednarczyk P; Nowak A; Duchnik W; Kucharski Ł; Ossowicz-Rupniewska P
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958615
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of Adhesive Properties of Transdermal Patches Distributing in Japan-Tack and Peel Strength].
Miyazaki T; Kanno H; Aso Y; Goda Y
Yakugaku Zasshi; 2018 Nov; 138(11):1425-1433. PubMed ID: 30146539
[TBL] [Abstract][Full Text] [Related]
20. In vitro efficacy and release study with anti-inflammatory drugs incorporated in adhesive transdermal drug delivery systems.
Meyer S; Peters N; Mann T; Wolber R; Pörtner R; Nierle J
J Pharm Sci; 2014 Apr; 103(4):1142-8. PubMed ID: 24633817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
